Back to CRVS
MORGAN STANLEY CRVS Position History
Corvus Pharmaceuticals, Inc. • Healthcare
Quarters held
22
Latest value
$75K
Q2 2026
Peak value
$27.2M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $3.9M |
| Q3 2025 | $319K |
| Q3 2025 | $353K |
| Q3 2025 | $3K |
| Q4 2025 | $4K |
| Q4 2025 | $4M |
| Q4 2025 | $78K |
| Q4 2025 | $20.3M |
| Q4 2025 | $3.1M |
| Q4 2025 | $15K |
| Q1 2026 | $14K |
| Q1 2026 | $6.9M |
| Q1 2026 | $8K |
| Q1 2026 | $2.3M |
| Q1 2026 | $27.2M |
| Q1 2026 | $109K |
| Q2 2026 | $18K |
| Q2 2026 | $8.7M |
| Q2 2026 | $84K |
| Q2 2026 | $945K |
| Q2 2026 | $10.3M |
| Q2 2026 | $75K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $75K | 5.0K | — | — |
| Q2 2026 | $10.3M | 689.2K | — | — |
| Q2 2026 | $945K | 63.3K | — | — |
| Q2 2026 | $84K | 5.6K | — | — |
| Q2 2026 | $8.7M | 580.4K | — | — |
| Q2 2026 | $18K | 1.2K | — | — |
| Q1 2026 | $109K | 7.4K | — | — |
| Q1 2026 | $27.2M | 1.86M | — | — |
| Q1 2026 | $2.3M | 159.5K | — | — |
| Q1 2026 | $8K | 542 | — | — |
| Q1 2026 | $6.9M | 472.0K | — | — |
| Q1 2026 | $14K | 934 | — | — |
| Q4 2025 | $15K | 2.0K | — | — |
| Q4 2025 | $3.1M | 400.9K | — | — |
| Q4 2025 | $20.3M | 2.64M | — | — |
| Q4 2025 | $78K | 10.2K | — | — |
| Q4 2025 | $4M | 517.4K | — | — |
| Q4 2025 | $4K | 493 | — | — |
| Q3 2025 | $3K | 469 | — | — |
| Q3 2025 | $353K | 47.9K | — | — |
| Q3 2025 | $319K | 43.3K | — | — |
| Q3 2025 | $3.9M | 525.6K | — | — |